Recombinant Human BIM (Long Form) Protein, CF

R&D Systems | Catalog # 1325-BL

R&D Systems
100% Guarantee

Key Product Details

  • R&D Systems E. coli-derived Recombinant Human BIM (Long Form) Protein (1325-BL)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

E. coli

Accession Number

NP_006529

Applications

Bioactivity
View all BIM Long (BIM L) Proteins and Enzymes »

Product Specifications

Source

E. coli-derived human BIM Long (BIM L) protein
Ala2-Arg120, with an N-terminal 6-His tag

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

N-terminal Sequence Analysis

His

Predicted Molecular Mass

14.3 kDa

SDS-PAGE

13-16 kDa and 30-35 kDa, reducing conditions

Activity

Measured by its ability to neutralize anti-apoptotic Bcl-2 family member inhibition of Recombinant Human BID Caspase-8-cleaved (Catalog # 882-B8)-mediated Cytochrome c release from isolated mitochondria. Release of Cytochrome c is quantified using the Rat/Mouse Cytochrome c Quantikine ELISA (Catalog # MCTC0).
The typical EC50 value in this assay is 0.1-2 µM.
Optimal dose should be determined for each application.

Formulation, Preparation, and Storage

1325-BL
Formulation Supplied as a 0.2 μm filtered solution in HEPES-KOH, DTT, KCl and Glycerol.
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Background: BIM Long (BIM L)

BIML (also known as Bod) is one of several splice variants of BIM, a pro-apoptotic protein belonging to the BH3 domain-only subgroup of Bcl-2 family members. BIML is thought to promote apoptosis by binding and inhibiting the activity of anti-apoptoticBcl-2 family members, thereby inducing the release of cytochrome c from mitochondria. BIML is normally sequestered in an inactive conformation from anti-apoptotic Bcl-2 family members through binding to the microtubule-associated dynein motor complex.Certain apoptotic stimuli release BIML from microtubules to neutralize anti-apoptotic Bcl-2 family members, allowing for the initiation of apoptosis.

References

  1. O'Connor, L. et al. (1998) EMBO J. 17:384.
  2. Puthalakath, H. et al. (1999) Mol. Cell. 3:287.
  3. Miyashita, T. (2001) FEBS Letters 509:135.
  4. Strasser, A. (2000) Ann N Y Acad Sci. 917:541.
  5. Marani, M. et al. (2002) Mol. Cell. Biol. 22:3577.

Long Name

Bcl-2 Interacting Mediator of Cell Death

Alternate Names

BCL2L11

Entrez Gene IDs

10018 (Human); 12125 (Mouse)

Gene Symbol

BCL2L11

UniProt

NP_006529

Additional BIM Long (BIM L) Products

Product Documents for Recombinant Human BIM (Long Form) Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Human BIM (Long Form) Protein, CF

For research use only

Related Research Areas

Bcl-2 Proteins and Regulators

Citations for Recombinant Human BIM (Long Form) Protein, CF

Customer Reviews for Recombinant Human BIM (Long Form) Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human BIM (Long Form) Protein, CF and earn rewards!

Have you used Recombinant Human BIM (Long Form) Protein, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for Recombinant Human BIM (Long Form) Protein, CF (1325-BL):

Materials
  • Recombinant Human BIML (Catalog # 1325-BL)
  • Recombinant Human BID Caspase-8-cleaved (Catalog # 882-B8)
  • Recombinant Human Bcl‑w Minus C-Terminus (Catalog # 824-BW)
  • Crude or enriched mouse liver mitochondria (See Preparation of mouse liver mitochondria at http://www.rndsystems.com/literature_cytochrome_c_release_assays_bcl-2.aspx)
  • Formulation Buffer: 20 mM Tris (pH 8.5), 150 mM NaCl, 1 mM Dtt, 20% Glycerol, 1 mg/mL fatty acid free BSA* (Sigma, Catalog # A6003)
  • BID Dilution Buffer: 25 mM HEPES-KOH (pH 7.4), 0.1 M KCl, 1 mg/mL fatty acid free BSA*
  • Mitochondria Buffer: 125 mM KCl, 0.5 mM MgCl2, 3.0 mM Succinic acid, 3.0 mM Glutamic acid, 10 mM HEPES-KOH, (pH 7.4), 1 mg/mL BSA*, containing 25 μg/mL Leupeptin, 25 μg/mL Pepstatin, 3 μg/mL Aprotinin, 100 μM PMSF, and 10 μM Boc-Asp-FMK caspase inhibitor
    *Note: Protease inhibitors and BSA should be added to the buffer immediately prior to use. 
    BSA stock solution should be prepared at 100 mg/mL.
    • Note: All buffers, proteins and tubes should be kept on ice until indicated. Assay volumes are 75 μL and are combined in 0.5 mL Eppendorf tubes.
    1. Prepare a stock solution of Recombinant Human Bcl‑w Minus C-Terminus (MW: 19.6 kDa) in Formulation Buffer at 59 μg/mL. The final concentration will be 600 nM. 
    2. Prepare dilutions of Recombinant Human BIML (MW: 14.3 kDa) in Formulation Buffer at concentrations of 15,000, 5000, 1500, 500, 150, 50, and 15 nM. The final concentration range will be 3000 to 3 nM in a total rxn volume of 75 μL.
    3. Aliquot 15 μL of each of the BIML dilutions to a series of tubes. Add 15 μL of the Recombinant Human Bcl‑w Minus C-Terminus to each tube and gently mix. Incubate for 60 minutes at room temperature. Include one sample without Recombinant Human BIML (cleaved BID/Bcl-w control).
    4. Prepare a stock solution of Recombinant Human BID Caspase-8-cleaved (MW: 22.0 kDa) in BID Dilution Buffer at 9.0 μg/mL. The final concentration will be 54 nM.
    5. Add 10 μL of the Recombinant Human BID Caspase-8-cleaved Recombinant Human BID to each tube and gently mix. Incubate for 60 minutes at room temperature. Include one sample without Recombinant Human BIML or Bcl‑w Minus C-Terminus (cleaved BID control).
    6. Add 12 μL of mitochondria (approximately 25-30 μg) and 23 μL of Mitochondria Buffer with added protease inhibitors and BSA to each tube.
    7. Two additional control samples must be run for each assay to determine the total amount of Cytochrome c that can be released from the mitochondria and the amount of spontaneously released Cytochrome c. Set up two samples containing only mitochondria and the appropriate buffers that have not been treated with any test proteins.
    8. Cap the tubes and gently mix the contents for 5-10 seconds. Incubate in a 30 °C water bath for 30 minutes.
    9. Total Cytochrome c in the assay should be determined by freezing the entire 75 μL rxn mix immediately after incubation at 30 °C.
    10. Centrifuge the remaining samples at 16,000 x g for 5 minutes at 2-8 °C. Remove and transfer a 50 μL aliquot of the supernatant to a new chilled tube. Samples may be analyzed immediately or stored at -20 °C in a manual defrost freezer.
    11. Measure the levels of Cytochrome c in these samples using the Rat/Mouse Cytochrome c Quantikine® ELISA Kit (Catalog # MCTC0). See the Preparation of Samples for the Cytochrome c ELISA at http://www.rndsystems.com/literature_cytochrome_c_release_assays_bcl-2.aspx and additional instructions in the Rat/Mouse Cytochrome c Quantikine ELISA Kit product insert (Catalog # MCTC0).

    FAQs

    No product specific FAQs exist for this product.

    View all FAQs for Proteins and Enzymes